Neoplasm by Special Category — Trials

Neoplasm by Special Category — Trials · CancerIndex

Clinical trials

Registered studies

95,753 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 551–600 of 2,547 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06212752	A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension	active not recruiting	Phase 3	39	Merck Sharp & Dohme LLCINDUSTRY	1	Aug 26, 2026	clinicaltrials
NCT06350097	Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer(TROPION-Lung14)	recruiting	Phase 3	582	AstraZeneca